Friday, 22 August 2008

Drug approvals: Pliva (Pamidronate Disodium Injection), Actavis (Bupropion Hydrochloride)

Pliva (Pamidronate Disodium Injection)
Pliva( subsidiary of Barr) has received final approval from the USFDA for its generic version of Hospira's Pamidronate Disodium Injection, 30mg/10mL, 60mg/10mL, and 90mg/10m
Actavis (Bupropion Hydrochloride)
Actavis received approval from the USFDA to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. The distribution of the tablets will commence immediately.

Posted by ADKS at 10:39 am

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker